Robert J. Ginsberg mainly focuses on Surgery, Lung cancer, Respiratory disease, Chemotherapy and Radiation therapy. His studies in Surgery integrate themes in fields like Lung and Pneumonectomy. His Lung cancer study integrates concerns from other disciplines, such as Lymph node, Pulmonary toxicity, Carcinoma and Induction chemotherapy.
The study incorporates disciplines such as Metastasectomy, Metastasis, Mediastinotomy and Respiratory failure in addition to Respiratory disease. The Chemotherapy study combines topics in areas such as Randomized controlled trial and Esophageal cancer. His biological study spans a wide range of topics, including Nuclear medicine, Clinical trial and Epidermoid carcinoma.
His primary areas of investigation include Surgery, Lung cancer, Chemotherapy, Internal medicine and Respiratory disease. His study in Surgery is interdisciplinary in nature, drawing from both Carcinoma and Pneumonectomy. His Pneumonectomy research incorporates themes from Dissection and Wedge resection.
His studies deal with areas such as Stage, Cancer and Radiology as well as Lung cancer. His research in Respiratory disease intersects with topics in Anesthesia, Complication and Metastasis. As part of one scientific family, Robert J. Ginsberg deals mainly with the area of Radiation therapy, narrowing it down to issues related to the Esophageal cancer, and often Esophagus.
Robert J. Ginsberg mainly focuses on Surgery, Lung cancer, Chemotherapy, Internal medicine and Radiation therapy. His Surgery research includes elements of Respiratory disease, Carcinoma and Pneumonectomy. His Respiratory disease research is multidisciplinary, incorporating elements of ARDS and Metastasis.
Robert J. Ginsberg has included themes like Carboplatin, Cancer and Radiology in his Lung cancer study. The various areas that Robert J. Ginsberg examines in his Chemotherapy study include Stage, Disease and Lung. His Radiation therapy research includes themes of Randomized controlled trial, Epidermoid carcinoma and Esophageal cancer.
The scientist’s investigation covers issues in Surgery, Chemotherapy, Lung cancer, Radiation therapy and Survival rate. Robert J. Ginsberg has researched Surgery in several fields, including Internal medicine, Oncology and Pneumonectomy. As part of the same scientific family, Robert J. Ginsberg usually focuses on Chemotherapy, concentrating on Respiratory disease and intersecting with Metastasis and Sarcoma.
His biological study deals with issues like Induction chemotherapy, which deal with fields such as Mediastinoscopy. His Radiation therapy study combines topics in areas such as Clinical trial, Epidermoid carcinoma, Nuclear medicine, Esophageal cancer and Stage. In Survival rate, Robert J. Ginsberg works on issues like Retrospective cohort study, which are connected to Disease, Positron emission tomography, Primary tumor, Thorax and Cause of death.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Robert J. Ginsberg;Lawrence V. Rubinstein.
The Annals of Thoracic Surgery (1995)
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
Bruce D. Minsky;Thomas F. Pajak;Robert J. Ginsberg;Thomas M. Pisansky.
Journal of Clinical Oncology (2002)
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan.
The New England Journal of Medicine (1998)
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
Nael Martini;Manjit S. Bains;Michael E. Burt;Maureen F. Zakowski.
The Journal of Thoracic and Cardiovascular Surgery (1995)
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.
Ugo Pastorino;Marc Buyse;Godehard Friedel;Robert J. Ginsberg.
The Journal of Thoracic and Cardiovascular Surgery (1997)
Modern thirty-day operative mortality for surgical resections in lung cancer.
R J Ginsberg;L D Hill;R T Eagan;P Thomas.
The Journal of Thoracic and Cardiovascular Surgery (1983)
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.
Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar.
Molecular Imaging and Biology (1999)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
Valerie W. Rusch;Kenneth Rosenzweig;Ennapadam Venkatraman;Larry Leon.
The Journal of Thoracic and Cardiovascular Surgery (2001)
Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of disease and postmetastasis survival
Kevin G. Billingsley;Michael E. Burt;Ellen Jara;Robert J. Ginsberg.
Annals of Surgery (1999)
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Nael Martini;Mark G. Kris;Betty J. Flehinger;Richard J. Gralla.
The Annals of Thoracic Surgery (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: